Delivery Order SPE2DB22D3011-SPE2DB24FP9JJ
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $14,295.00 award is for the supply of GAMUNEX-C 20 gram/200 ml vials, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of GAMUNEX-C 40 gram/400 ml vial pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order has a ceiling value of $14,427.24 and a performance period through April 25, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,161.68, is for the delivery of GAMUNEX-C 20 gram/200 ml vials, a pharmaceutical product, with a completion date of May 1, 2025. The contract is a firm fixed-price delivery order, and it is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a substantial Indefinite...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $55,852.80 firm fixed-price delivery order is for the supply of GAMUNEX-C, a 40 gram/400 ml vial medication, with an ultimate completion date of March 31, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $14,295.00 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product GAMUNEX-C 20 GRAM/200 ML VIAL 200ML, with a completion date of February 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,220.94, is for the supply of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, a medical product. The contract has an ultimate completion date of April 1, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 40 gram/400 ml vials. The award, valued at $4,809.08, is a firm fixed-price contract with a completion date of August 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of medical...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $57,708.96 award is for the delivery of GAMUNEX-C 40 gram/400 ml vials to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract with a potential value of $999,999,999.00 through December 2025 as...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,963.20, is for the delivery of GAMUNEX-C 40 gram/400 ml vials, a specialty medication. The contract has an ultimate completion date of February 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- The Defense Logistics Agency (DLA) awarded a $14,295.00 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The order is for 200 ml vials of GAMUNEX-C, a pharmaceutical product, with a completion date of March 7, 2024. This delivery order falls under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FP9JJDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $14,295.00 order is for the delivery of GAMUNEX-C 20 gram/200 ml vials to be completed by March 13, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order was issued under that IDC. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 2/21/24 |